According to Market Research Future (MRFR), a leading research firm, the global vitamin K2 market is expected to reach USD 228.27 MN by 2023. MRFR, in its recent study report, also asserts that the market would register 5.80% CAGR over the assessment period (2017 – 2023).
Vitamin K2 or menaquinones helps the absorption of calcium in the bone matrix and prevent its deposition in the arteries. This vitamin is helpful in the treatment of cardiovascular diseases and bone diseases. Besides, the vitamin is also used in the production of various nutraceutical, food, pharmaceutical, and other products. Over the past few years, the global vitamin K2 market has been growing continuously, mainly due to the rising demand for health supplements.
Public health agencies are focusing on the consumption of dietary and nutrition supplements, focus increasingly to control the prevalence of osteoporosis and chronic diseases. Factors such as growing awareness of vitamin K2s and advancements in production techniques are contributing to the growth of the market, hugely. Besides, rising immunity disorders led by the changing and sedentary lifestyle and addictions such as smoking & alcoholism are propelling the growth of the market.
Major Players
Players leading the global vitamin K2 market, includes-
NattoPharma (Norway)
Kappa Bioscience (Norway)
Gnosis SpA (Italy)
Seebio Biotech (China)
Viridis BioPharma (India)
DSM (The Netherlands)
Geneferm Biotechnology Co. Ltd. (Taiwan)
Danisco A/S (US)
Kyowa Hakko Bio Co. Ltd. (Japan)
Frutarom (Israel)
and among others.
Avail FREE Sample at: https://www.marketresearchfuture.com/sample_request/7495
Global Vitamin K2 Market – Segments
The market report has five dynamics to widen the scope of understanding,
By Product Type : MK-7, MK-4, and others.
By Source : Natural and Synthetic
By Form : Oil, Powder, and others.
By Application : Nutraceutical, Food, Pharmaceutical, and others.
By Regions : Europe, North America, APAC, and the Rest-of-the-World (RoW).
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Rivalry
5.2 Supply Chain Analysis
5.2.1 Raw Material Planning & Procurement
5.2.2 Packaging
5.2.3 Transportation
5.2.4 Distribution Marketing & Sales
5.2.5 Post-sales Services
Industry Advancements/Related News
October 1, 2019 —- Kappa Bioscience (Norway), a leading manufacturer vital vitamins K2 & MK-7, announced its plan to unveil the results of an extensive study on vitamin K2 quality at SupplySide West in Las Vegas, NV. The findings of research show an increased use of stability-enhanced K2 MK-7 among manufacturers. On June 21, 2019, the Vitamin K2 supplier had launched a new 1% high-concentrate version of its K2Vital Delta ingredient. The K2Vital Delta line comprises microencapsulated vitamin K2 MK-7.
Browse Complete Premium Research Report at: https://www.marketresearchfuture.com/reports/vitamin-k2-market-7495
Global Vitamin K2 Market – Regional Analysis
North America leads the global vitamin K2 market due to the increasing demand for nutritional products. The rising prevalence of cardiovascular diseases and bone diseases is driving the vitamin K2 market, creating a huge market demand in the region. Moreover, increasing occurrences of low immunity disorders have been driving the regional market growth, leading to an increased focus on preventive health care.
The vitamin K2 market in the European region stands second, globally. The rising demand for vitamin supplements in Germany, France, and the UK is triggering regional market growth. Besides, the presence of advanced healthcare infrastructure, alongside the increasing healthcare expenditures are driving market growth in the region, predominantly.
Also, the growing awareness about the importance of vitamin K2 influences the market growth in this region. Additionally, factors such as the rising growth in the various nutritional products such as supplements, functional food, and others increase the demand in the regional market.
The Asia Pacific vitamin K2 market is emerging as a profitable market globally. Rapid growth in healthcare sectors and the adoption of advanced technology offer enormous growth opportunities to market players. Substantially larger markets in New Zealand and China lead in the regional market.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/vitamin-k2-market-7495